Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Witkin

Showing results (271-280 of 321) with videos related to

Pageof 33
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 8, 2019
The Positive Allosteric Modulator of <i>α</i>2/3-Containing GABA<sub>A</sub> Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain InjuryJeffrey M Witkin, Guanguan Li, Lalit K Golani, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood CircuitsJ M Witkin, J A Monn, D D Schoepp, et al.
Molecular Psychiatry|October 19, 2005
Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetineE T Tzavara, F P Bymaster, C D Overshiner, et al.
Biochemical Pharmacology|May 19, 2024
AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefitJeffrey M Witkin, Daniel P Radin, Sabhya Rana, et al.
Pain|August 23, 2016
Hedonic and motivational responses to food reward are unchanged in rats with neuropathic painAlec Okun, David L McKinzie, Jeffrey M Witkin, et al.
Pharmacology, Biochemistry, and Behavior|July 16, 2020
The α2,3-selective potentiators of GABA<sub>A</sub> receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance developmentA Biggerstaff, B Kivell, J L Smith, et al.
ACS Chemical Neuroscience|August 22, 2017
Structural Determinants of the γ-8 TARP Dependent AMPA Receptor AntagonistMatthew R Lee, Kevin M Gardinier, Douglas L Gernert, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2012
In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorderV Barth, A B Need, E T Tzavara, et al.
CNS & Neurological Disorders Drug Targets|April 12, 2013
mGlu2/3 agonist-induced hyperthermia: an in vivo assay for detection of mGlu2/3 receptor antagonism and its relation to antidepressant-like efficacy in miceS D Gleason, X Li, I A Smith, et al.
CNS & Neurological Disorders Drug Targets|April 30, 2015
Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8 Through Investigations of TARP γ-8 Null Mice§Scott D Gleason, Akihiko Kato, Hai H Bui, et al.
Pageof 33

Showing results (271-280 of 321) with videos related to

Sort By:
Pageof 33
The Journal of Pharmacology and Experimental Therapeutics|November 8, 2019
The Positive Allosteric Modulator of <i>α</i>2/3-Containing GABA<sub>A</sub> Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain InjuryJeffrey M Witkin, Guanguan Li, Lalit K Golani, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood CircuitsJ M Witkin, J A Monn, D D Schoepp, et al.
Molecular Psychiatry|October 19, 2005
Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetineE T Tzavara, F P Bymaster, C D Overshiner, et al.
Biochemical Pharmacology|May 19, 2024
AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefitJeffrey M Witkin, Daniel P Radin, Sabhya Rana, et al.
Pain|August 23, 2016
Hedonic and motivational responses to food reward are unchanged in rats with neuropathic painAlec Okun, David L McKinzie, Jeffrey M Witkin, et al.
Pharmacology, Biochemistry, and Behavior|July 16, 2020
The α2,3-selective potentiators of GABA<sub>A</sub> receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance developmentA Biggerstaff, B Kivell, J L Smith, et al.
ACS Chemical Neuroscience|August 22, 2017
Structural Determinants of the γ-8 TARP Dependent AMPA Receptor AntagonistMatthew R Lee, Kevin M Gardinier, Douglas L Gernert, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2012
In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorderV Barth, A B Need, E T Tzavara, et al.
CNS & Neurological Disorders Drug Targets|April 12, 2013
mGlu2/3 agonist-induced hyperthermia: an in vivo assay for detection of mGlu2/3 receptor antagonism and its relation to antidepressant-like efficacy in miceS D Gleason, X Li, I A Smith, et al.
CNS & Neurological Disorders Drug Targets|April 30, 2015
Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8 Through Investigations of TARP γ-8 Null Mice§Scott D Gleason, Akihiko Kato, Hai H Bui, et al.
Pageof 33